Psoriasis Club
  • Forum
  • Home
  • Portal
  • Member List
  • Psoriasis Score
  • PQOLS
  • What is psoriasis
  • Search
  • Help
Hello Guest, Welcome To The Psoriasis Club Forum. We are a self funded friendly group of people who understand.
Never be alone with psoriasis, come and join us. (Members have more privileges)
wave
Login Register
Login
Username:
Password:
Lost Password?
 
Psoriasis Club › HealthHealth Boards › Psoriasis In The News v
1 2 3 4 5 … 49 Next »

Cosentyx better than nb-UVB in treating patients with new onset psoriasis

Threaded Mode
Cosentyx better than nb-UVB in treating patients with new onset psoriasis
Fred Offline
I Wanted To Change the World But Got Up Far Too Late.
Moderator
Posts: 56,855
Threads: 3,549
Joined: Aug 2011
Gender: Male
Location: France
Psoriasis Score: 2
Psoriatic Arthritis Score: 1
PQOLS: 2
Treatment: Bimzelx / Coconut Oil
#1
News  Sat-07-01-2023, 13:55 PM
This study compared Cosentyx (secukinumab) with narrow band ultraviolet B (nb-UVB) phototherapy in new onset moderate to severe plaque psoriasis patients.

Quote:
Background:
Biologic treatments have been studied mainly in patients with a long-term history of psoriasis and previous treatment failures.

Objectives:
The purpose of this primary analysis of the STEPIn study is to determine whether early intervention with secukinumab in patients with new-onset moderate to severe plaque psoriasis is superior to standard of care treatment with narrow band ultraviolet B (nb-UVB) phototherapy.

Methods:
The STEPIn study is a randomised, open-label, multicentre study to investigate early intervention with 52 weeks of secukinumab 300 mg administered subcutaneously vs. standard treatment with nb-UVB phototherapy in patients with new-onset (≤12 months) moderate to severe plaque psoriasis (NCT03020199). The primary and additional secondary endpoints were ≥90% improvement in Psoriasis Area and Severity Index (PASI 90) at Week 52 and Investigator's Global Assessment (IGA mod 2011) 0/1 response at Week 52, respectively.

Results:
In the secukinumab and nb-UVB study arms, 77/80 and 76/80 randomised patients received at least one dose of study treatment, respectively. The primary endpoint was achieved: 91.1% (70/77) of patients achieved a PASI 90 response at Week 52 in the secukinumab arm vs. 42.3% (32/76) in the nb-UVB arm (P<0.0001, odds ratio [OR] estimate [95% confidence intervals, CI] = 16.3 [5.6, 46.9]). The additional secondary endpoint was also achieved: 85.7% of patients achieved an IGA 0/1 response at Week 52 in the secukinumab arm vs. 36.8% in the nb-UVB arm (P<0.0001). The safety data were consistent with the safety profiles of secukinumab and nb-UVB with no new or unexpected safety signals.

Conclusions:
Secukinumab was superior to nb-UVB in treating patients with new-onset moderate to severe plaque psoriasis. The high and sustained skin clearance observed indicates that biologic treatment for psoriasis may be more effective if used early in the disease course.

Source: onlinelibrary.wiley.com

*Early view funding unknown

Cosentyx (secukinumab)
Quote
Turnedlight Offline
100 + Member I Just Cant Stop !

100 + Member I Just Cant Stop !
Posts: 3,944
Threads: 44
Joined: Apr 2015
Gender: Female
Location: Uk
Treatment: Skyrizi
#2
Fri-13-01-2023, 17:04 PM (This post was last modified: Fri-13-01-2023, 17:04 PM by Turnedlight.)
Huh my psoriasis was made much worse by being forced to have uvb and getting burned by it on areas I didn’t have any P.

No way are they ever going to change their current approach of giving us the cheapest worst drugs/ treatment first.
Quote
Fred Offline Author
I Wanted To Change the World But Got Up Far Too Late.
Moderator
Posts: 56,855
Threads: 3,549
Joined: Aug 2011
Gender: Male
Location: France
Psoriasis Score: 2
Psoriatic Arthritis Score: 1
PQOLS: 2
Treatment: Bimzelx / Coconut Oil
#3
Fri-13-01-2023, 21:08 PM
(Fri-13-01-2023, 17:04 PM)Turnedlight Wrote: No way are they ever going to change their current approach of giving us the cheapest worst drugs/ treatment first.

They do the same here TL, I can't help feeling it would be better and cheaper in the long run to go in with a bio on newly diagnosed. We all know the creams, light and poisons like methotrexate don't work and people will end up on a bio anyway eventually.

Hit hard first off with a bio and it may be possible to send it in remission with only a booster once per year, but hey they don't make money that way do they. Whistle
Quote
« Next Oldest | Next Newest »


Possibly Related Threads…
Thread Author Replies Views Last Post
News Bio's for psoriasis in HIV patients Fred 1 222 Sun-12-03-2023, 16:02 PM
Last Post: Caroline
News Increased Risk of Suicidality in Patients with Psoriasis Fred 3 1,025 Sun-28-08-2022, 10:56 AM
Last Post: Fred
News Metabolic syndrome more common in patients with psoriatic arthritis Fred 6 3,453 Fri-01-07-2022, 20:51 PM
Last Post: Caroline
News Effectiveness of (IL)-17A to other biologics in patients with psoriasis Fred 3 1,199 Fri-01-07-2022, 11:57 AM
Last Post: Fred
News Ilumya / Ilumetri in patients with psoriasis and metabolic syndrome Fred 2 811 Fri-01-07-2022, 11:51 AM
Last Post: Fred



Users browsing this thread: 1 Guest(s)
    Contact us | Login | Register | Home | Cookies/GDPR | RSS Syndication | Portal | Types Of Psoriasis | Psoriasis Score | Members Only Boards
    Copyright © 2010 - 2023 Psoriasis Club All Rights Reserved | Founded May 2010 | Psoriasis Club Is Self Funded Without Sponsors Or Donations | Software by MyBB | Social
Linear Mode
Threaded Mode